tiprankstipranks
Trending News
More News >
Avecho Biotechnology Limited (AU:AVE)
ASX:AVE
Australian Market

Avecho Biotechnology Limited (AVE) Financial Statements

Compare
9 Followers

Avecho Biotechnology Limited Financial Overview

Avecho Biotechnology Limited's market cap is currently AU$36.73M. The company's EPS TTM is AU$-0.001; its P/E ratio is -9.09; Avecho Biotechnology Limited is scheduled to report earnings on September 1, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueAU$ 1.13MAU$ 473.55KAU$ 1.13MAU$ 793.60KAU$ 384.63K
Gross ProfitAU$ 671.93KAU$ -43.80KAU$ 793.12KAU$ 507.94KAU$ 240.91K
Operating IncomeAU$ -4.96MAU$ -4.59MAU$ -3.06MAU$ -4.55MAU$ -3.39M
EBITDAAU$ -2.92MAU$ -3.24MAU$ -2.11MAU$ -2.98MAU$ -2.45M
Net IncomeAU$ -3.12MAU$ -3.44MAU$ -2.34MAU$ -3.42MAU$ -2.63M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 2.37MAU$ 5.50MAU$ 1.47MAU$ 3.26MAU$ 1.87M
Total AssetsAU$ 5.00MAU$ 7.32MAU$ 3.35MAU$ 5.25MAU$ 3.35M
Total DebtAU$ 1.08MAU$ 175.15KAU$ 246.07KAU$ 93.91KAU$ 166.23K
Net DebtAU$ -1.30MAU$ -5.33MAU$ -1.22MAU$ -3.17MAU$ -1.71M
Total LiabilitiesAU$ 1.73MAU$ 941.54KAU$ 920.66KAU$ 709.36KAU$ 700.17K
Stockholders' EquityAU$ 3.27MAU$ 6.38MAU$ 2.42MAU$ 4.54MAU$ 2.65M
Cash Flow
Free Cash FlowAU$ -3.97MAU$ -3.18MAU$ -1.72MAU$ -3.30MAU$ -1.43M
Operating Cash FlowAU$ -3.97MAU$ -3.18MAU$ -1.67MAU$ -3.10MAU$ -1.42M
Investing Cash FlowAU$ -15.73KAU$ 0.00AU$ -53.12KAU$ -202.82KAU$ -5.15K
Financing Cash FlowAU$ 854.59KAU$ 7.22MAU$ -78.22KAU$ 4.69MAU$ -82.50K
Currency in AUD

Avecho Biotechnology Limited Earnings and Revenue History

Avecho Biotechnology Limited Debt to Assets

Avecho Biotechnology Limited Cash Flow

Avecho Biotechnology Limited Forecast EPS vs Actual EPS